SGLT-2 Inhibition, Metabolomics and Cardiovascular/Kidney Disease

Clinical trial NCT03919656 · COMPLETED

Trial details

NCT number: NCT03919656
Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2019-05-12
Primary completion: 2024-01-12
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.